Nonintubated video-assisted thoracic surgery with high-flow oxygen therapy shorten hospital stay.
Journal
Journal of the Chinese Medical Association : JCMA
ISSN: 1728-7731
Titre abrégé: J Chin Med Assoc
Pays: Netherlands
ID NLM: 101174817
Informations de publication
Date de publication:
Oct 2020
Oct 2020
Historique:
entrez:
3
10
2020
pubmed:
4
10
2020
medline:
16
11
2021
Statut:
ppublish
Résumé
Nonintubated video-assisted thoracic surgery (VATS) is widely used due to its acceptable postoperative outcomes. Transnasal humidified rapid-insufflation ventilatory exchange (THRIVE) has been successfully applied in cases of prolonged difficult intubation and intensive respiratory care in patients receiving VATS lobectomy. Thopaz Digital Chest Drainage System (THOPAZ) provides regulated negative pressure close to the patient's chest, optimizing drainage of the pleural and mediastinum. We explored the surgical outcomes of nonintubated VATS lung wedge resection and traditional wedge resection with a double-lumen endotracheal tube. Patients who received nonintubated VATS lung wedge resection (group A, n = 81) and traditional wedge resection with double-lumen endotracheal tube (group B, n = 79) during the period of November 2015 to April 2018 were enrolled in the study. Demographic data and operation outcomes were obtained and analyzed from review of patient medical charts. Group B had significantly longer mean induction and operative times than group A. Similarly, group B suffered greater intraoperative blood loss, longer postoperative hospital stays, and increased chest tube retention times than group A. Group A had higher partial pressure of carbon dioxide levels in both the pre-one-lung and during one-lung ventilation periods than group B. Furthermore, group A showed lower serum pH levels during one-lung ventilation period. However; group A had significantly higher partial pressure of oxygen levels during one-lung ventilation than group B, although the differences in peripheral oxygen saturation were not statistically significant. Our study demonstrated that nonintubated VATS using THRIVE and THOPAZ in lung wedge resection provides measurable benefits to patients.
Sections du résumé
BACKGROUND
BACKGROUND
Nonintubated video-assisted thoracic surgery (VATS) is widely used due to its acceptable postoperative outcomes. Transnasal humidified rapid-insufflation ventilatory exchange (THRIVE) has been successfully applied in cases of prolonged difficult intubation and intensive respiratory care in patients receiving VATS lobectomy. Thopaz Digital Chest Drainage System (THOPAZ) provides regulated negative pressure close to the patient's chest, optimizing drainage of the pleural and mediastinum. We explored the surgical outcomes of nonintubated VATS lung wedge resection and traditional wedge resection with a double-lumen endotracheal tube.
METHODS
METHODS
Patients who received nonintubated VATS lung wedge resection (group A, n = 81) and traditional wedge resection with double-lumen endotracheal tube (group B, n = 79) during the period of November 2015 to April 2018 were enrolled in the study. Demographic data and operation outcomes were obtained and analyzed from review of patient medical charts.
RESULTS
RESULTS
Group B had significantly longer mean induction and operative times than group A. Similarly, group B suffered greater intraoperative blood loss, longer postoperative hospital stays, and increased chest tube retention times than group A. Group A had higher partial pressure of carbon dioxide levels in both the pre-one-lung and during one-lung ventilation periods than group B. Furthermore, group A showed lower serum pH levels during one-lung ventilation period. However; group A had significantly higher partial pressure of oxygen levels during one-lung ventilation than group B, although the differences in peripheral oxygen saturation were not statistically significant.
CONCLUSION
CONCLUSIONS
Our study demonstrated that nonintubated VATS using THRIVE and THOPAZ in lung wedge resection provides measurable benefits to patients.
Identifiants
pubmed: 33009243
doi: 10.1097/JCMA.0000000000000408
pii: 02118582-202010000-00013
pmc: PMC7526565
doi:
Substances chimiques
Carbon Dioxide
142M471B3J
Oxygen
S88TT14065
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
943-949Commentaires et corrections
Type : CommentIn
Références
J Thorac Dis. 2016 Feb;8(Suppl 1):S55-64
pubmed: 26941971
Aust Crit Care. 2007 Nov;20(4):126-31
pubmed: 17931878
Indian J Anaesth. 2011 Nov;55(6):636-7
pubmed: 22223921
Gen Thorac Cardiovasc Surg. 2014 Dec;62(12):730-3
pubmed: 23807399
Br J Anaesth. 2017 Mar 1;118(3):444-451
pubmed: 28203745
Anaesthesia. 2015 Mar;70(3):323-9
pubmed: 25388828
Clin Respir J. 2018 Apr;12(4):1454-1459
pubmed: 28776940
Acta Anaesthesiol Scand. 1997 Oct;41(9):1095-1103
pubmed: 9366929
South Med J. 1988 Jun;81(6):739-44
pubmed: 3131883
Ann Surg. 2011 Dec;254(6):1038-43
pubmed: 21869676
J Appl Physiol (1985). 2015 Jun 15;118(12):1525-32
pubmed: 25882385
Eur J Cardiothorac Surg. 2009 May;35(5):822-8; discussion 828
pubmed: 19233672
J Cardiothorac Vasc Anesth. 1999 Jun;13(3):322-9
pubmed: 10392687
Chin J Cancer Res. 2014 Aug;26(4):364-7
pubmed: 25232206
Anesth Analg. 2016 Oct;123(4):859-68
pubmed: 27537929
Ann Thorac Surg. 2013 Oct;96(4):1209-1215
pubmed: 23998413
Eur J Cardiothorac Surg. 2018 May 1;53(5):1001-1006
pubmed: 29253106
J Cardiothorac Surg. 2011 Apr 21;6:59
pubmed: 21510897
Respir Care. 2016 Apr;61(4):529-41
pubmed: 27016353
Respir Care. 2013 Oct;58(10):1621-4
pubmed: 23513246